Scroll down for my resume ↓

01 · bio

The dish.

Every cell here is running the cell cycle: it grows, copies its DNA, and splits in two. Watch the chromosomes line up and get pulled apart. Click any cell to follow it.

flow cytometry · live singlets
G0/G1 2N, growing
S EdU+, copying DNA
G2 4N, pH3−
M 4N, pH3+
DAPI · EdU · pH3 · viability
in the dish: 0 cells · 0 divisions · gen 0
following cell

#0

G1
generation
0
daughter of
founder
age
0 s
next division
0 s
microscope

click a cell, then scroll to dive into its DNA · double-click to seed a cell

resume · bio

In the lab.

Four years of wet-lab research, from cancer drug synthesis to vesicle engineering.

Download the full resume (PDF) ↗

Publications & conferences

  1. Paper
    Coauthor, “Synthesis, antiproliferative activity, and biological profiling of C-19 trityl and silyl ether andrographolide analogs in colon cancer and breast cancer cells.” Bioorganic & Medicinal Chemistry Letters 121, 130163 (2025). DOI ↗ PubMed ↗
  2. In prep
    Multiplex 3D-printed diffusion platform for high-throughput transdermal delivery testing. Manuscript in preparation for Nature Biomedical Engineering (impact factor 26.3).
  3. ACS
    Poster, American Chemical Society Fall 2024, board 607: “Discovery, synthesis, and optimization of 5-phenylisoxazole based covalent inhibitors targeting G12C mutant KRAS for the treatment of cancer.” Record ↗
  4. WCBSURC 2023
    Presented the KRAS G12C work at the West Coast Biological Sciences Undergraduate Research Conference.
  5. SCCUR
    Data submitted to the Southern California Conference for Undergraduate Research. I couldn't attend, so I'm not on the presenters list.
  6. NCUR
    Abstract accepted to the National Conference on Undergraduate Research.
  7. Reviews
    “An Analysis on the Viability of DNMT Inhibitors in Cancer Treatment” and “Dendritic Cells and Their Role in Immunotherapy”, Research Archive of Rising Scholars preprints, with Aditya Bhaskara and Samarth Shah (2024). (It was a quick review paper that me and my friends did in 1 night lol) DNMT ↗ Dendritic cells ↗

Sep 2026 – now

Undergraduate Researcher, Miqin Zhang Lab

University of Washington · Seattle, WA

  • Developing polymer-coated iron oxide nanoparticles for targeted RNA delivery to pediatric brain tumors, using PEG/PEI conjugation and T7/CCT to support blood–brain barrier transport and tumor-cell uptake.

Oct 2026 – now

Undergraduate Researcher, Straehla Lab

University of Washington · Seattle, WA

  • Joining Maurice Lewis to study lipid nanoparticle (LNP) formulation and its applications in drug delivery.

Jan 2025 – Jul 2026

Lead Researcher, Pazzi Lab

reThink64 · Bioengineering · Fremont, CA

  • Lipid-vesicle research across GUVs, MLVs and lipid nanoparticles, using fluorescence microscopy, ImageJ and dynamic light scattering.
  • MLV hydration study (senior project): ran the NaCl and CaCl₂ screens on DOPC vesicles, imaged by fluorescence microscopy and measured in ImageJ. Team poster: “High Yields of Multilamellar Vesicles using Monovalent Ionic Buffers.”
  • GUV formation: tested four of the group's ten film solvents (acetone, ethanol, isopropanol and chloroform) and their evaporation conditions.
  • Membrane rupture: carmofur-analog studies using GUV popping assays.
  • Transdermal delivery: ran delivery testing on a 3D-printed multiplex diffusion platform (up to 96 parallel trials); the manuscript is in preparation for Nature Biomedical Engineering (impact factor 26.3).
  • Lab software: built custom APIs and Model Context Protocol (MCP) servers connecting Claude to the plate reader, HPLC, LC-MS, UV-Vis and NMR, plus a dashboard and Matplotlib analysis scripts.
  • Also: a skin-mimetic MLV platform for cosmetic delivery.

Sep 2022 – Jan 2025

Lead Researcher, Zhang Lab

ASDRP · Biological Chemistry · Fremont, CA

  • Coauthor, “Synthesis, antiproliferative activity, and biological profiling of C-19 trityl and silyl ether andrographolide analogs in colon cancer and breast cancer cells,” Bioorganic & Medicinal Chemistry Letters 121, 130163 (2025).
  • KRAS G12C inhibitors: ran MTT, colony-formation and transwell-migration assays for 5 of 12 5-phenylisoxazole compounds across Calu-1, HCT116, MDA-MB-231 and MCF7 cells. Presented at WCBSURC 2023 and ACS Fall 2024 (see above).
  • Combination therapy: with two partners, ran every single-agent and combination MTT screen of cisplatin with podophyllotoxin derivatives in HCT116 and MDA-MB-231.
  • Immunomodulation: ran Jurkat suspension MTT assays and set up an NK-92MI/tumor 3D coculture model for new andrographolide analogs, until the project's funding ran out.
  • Group leader who trained newer lab members. Tissue culture, MTT, colony and scratch-migration assays, Western blotting, qPCR.

Paper (DOI) ↗PubMed ↗ACS poster record ↗

Jul – Sep 2025

Research Intern, Global Change Research Group

San Diego State University · Ecosystem Science · San Diego, CA

  • Vibecoded Python pipelines, plus some R, to process large environmental datasets and study how ecosystems respond to global change.
  • Statistics on top: n-way ANOVAs, PCA on remote-sensing imagery, and Monte Carlo uncertainty modeling of carbon and water fluxes from soil sensors and eddy covariance towers.

Nov 2022 – Jun 2023

Therapeutic Support Specialist Intern

Allé Cauterucci · Support & Education · Fremont, CA

  • Built and ran individualized daily schedules for nine neurodivergent students, and met with parents about progress and goals.
  • Classroom teaching assistant, handling day-to-day classes and operations.

Grade 12

Honors Biology Teaching Assistant

BASIS Independent Fremont Upper

  • Teaching assistant for the Honors Biology class.